Mingxing Qiu

机构：Fourth People's Hospital of Sichuan Province, Key Laboratory of Guangdong Province, Nanfang Hospital, Sichuan Provincial Hospital of Traditional Chinese Medicine, Southern Medical University

发表论文 42 篇 · 总被引 528 次 · h-index 12

代表论文

• miR-7-5p acts as a tumor suppressor in bladder cancer by regulating the hedgehog pathway factor Gli3 (2018 · Biochemical and Biophysical Research Communications · 被引 47)
• miR-143 Induces the Apoptosis of Prostate Cancer LNCap Cells by Suppressing Bcl-2 Expression (2017 · Medical Science Monitor · 被引 46)
• Expression of CD44 and the survival in glioma: a meta-analysis (2020 · Bioscience Reports · 被引 41)
• RETRACTED: Polydatin protects against calcium oxalate crystal-induced renal injury through the cytoplasmic/mitochondrial reactive oxygen species-NLRP3 inflammasome pathway (2023 · Biomedicine & Pharmacotherapy · 被引 38)
• Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis (2023 · eLife · 被引 38)
• Dual-Ligand-Functionalized Liposomes Based on Glycyrrhetinic Acid and cRGD for Hepatocellular Carcinoma Targeting and Therapy (2023 · Molecular Pharmaceutics · 被引 36)